Kevin Koch - President and CEO, Director at Edgewise Therapeutics, Inc.

Issuer-level insider activity

Role
President and CEO, Director
Issuer ticker
EWTX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Kevin Koch in Edgewise Therapeutics, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-17,971
Avg price
$43.68
Total value
-$785,042

Net

Past year
Shares
-17,971
Share %
-100%
Total value
-$785,042

Reported holdings for Kevin Koch in Edgewise Therapeutics, Inc.

Form 4 holding President and CEO, Director

Edgewise Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
100,000
Estimated value
$1,359,156
Report date
12 Aug 2026
Price
$18.91
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Kevin Koch in Edgewise Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .